Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-09-19
2006-09-19
Balasubramanian, Venkataraman (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S377000, C548S190000, C548S233000
Reexamination Certificate
active
07109224
ABSTRACT:
Acyl guanidine compounds of the following Formulawherein R1, R2, R3, R4and L are described herein, and pharmaceutical compositions thereof, are useful in treating leukocyte activation-associated disorders.
REFERENCES:
patent: 4246406 (1981-01-01), Cragoe, Jr. et al.
patent: 4933355 (1990-06-01), Yoshioka et al.
patent: 5185334 (1993-02-01), Solomon et al.
patent: 5308857 (1994-05-01), Takasugi et al.
patent: 5449680 (1995-09-01), Solomon et al.
patent: 5527896 (1996-06-01), Wigler et al.
patent: 5977305 (1999-11-01), Wigler et al.
patent: 6297233 (2001-10-01), Stein et al.
patent: 6-138504 (1994-05-01), None
Wolft Manfred E. “Burger's Medicinal Chemistry, 5ed, Part 1”, John Wiley & Sons, 1995, pp. 975-977.
Banker, G.S. et al, “Modern Pharmaceutices, 3ed.”, Marcel Dekker, New York. 1996, pp. 451 and 596.
West, Anthony R., Solid State Chemistry and its Applications, Wiley, New York, 1988, pp. 358 & 365.
Vippagunta et al., Advanced Drug Delivery Reviews 48: 3-26, 2001.
Cecil Textbook of Medicine, edited by Bennet, J.C., and Plum F., 20th edition,vol. 1, 1004-1010, 1996.
Goronzy et al., Curr. Opin.. Rheumatol. 16(3)212-217, 2004.
Dorner et al., Curr. Opin.. Rheumatol. 16(3)246-263, 2004.
Beyer, H. et al., “Über Thiazole XL: Synthesen von Thiazolyl-(2)-guanidinen”, Chemische Berichte, vol. 95, pp. 893-901 (1962).
Fahmy, S.M. et al., “Reactions with Heterocyclic Amidines, X: Synthesis of Some New Azolylthiourea Derivatives”, Arch. Pharm. (Weinheim), vol. 315, pp. 791-797 (1982).
Fahmy, S.M. et al., “Reactions with Heterocyclic Amidines, X: Synthesis of Some New Azolylthiourea Derivatives”, Iraqi J. Sci., vol. 23, No. 1, pp. 28-41 (1982).
Han, P. et al., “Alternative Splicing of the High Affinity cAMP-Specific Phosphodiesterase (PDE7A) mRNA in Human Skeletal Muscle and Heart”, The Journal of Biological Chemistry, vol. 272, No. 26, pp. 16152-16157 (1997).
Henry, J.R. et al., “p38 mitogen-activated protein kinase as a target for drug discovery”, Drugs of the Future, vol. 24, No. 12, pp. 1345-1354 (1999).
Hurst, D.T. et al., “The Synthesis of Some Pyrimidinyl and Thiazolyl Ureas and Thioureas and Some Related Compounds”, Aust. J. Chem., vol. 41, pp. 1221-1229 (1988).
Li, L. et al., “CD3- and CD28-Dependent Induction of PDE7 Required for T Cell Activation”, Science, vol. 283, pp. 848-851 (1999).
Moreland, L.W. et al., “Etanercept Therapy in Rheumatoid Arthritis: A Randomized, Controlled Trial”, Ann. Intern. Med., vol. 130, pp. 478-486 (1999).
Nakata, A. et al., “Potential role of phosphodiesterase 7 in human T cell function: comparative effects of two phosphodiesterase inhibitors”, Clin. Exp. Immunol., vol. 128, pp. 460-466 (2002).
Rankin, E.C.C. et al., “The Therapeutic Effects of an Engineered Human Anti-Tumor Necrosis Factor Alpha Antibody (CDP571) in Rheumatoid Arthritis”, British Journal of Rheumatology, vol. 34, pp. 334-342 (1995).
Salituro, F.G. et al., “Inhibitors of p38 MAP Kinase: Therapeutic Intervention in Cytokine-Mediated Diseases”, Current Medicinal Chemistry, vol. 6, pp. 807-823 (1999).
Sasaki, T. et al., “Identification of Human PDE7B, a cAMP-Specific Phosphodiesterase”, Biochemical and Biophysical Research Communications, vol. 271, pp. 575-583 (2000).
Kempson James
Pitts William J.
Balasubramanian Venkataraman
Bristol-Myers Squibb Co.
Duncan Laurelee A.
LandOfFree
Acyl guanidine compounds and use thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Acyl guanidine compounds and use thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Acyl guanidine compounds and use thereof will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3530014